Pediatrix Medical (MD) EBIT (2009 - 2026)

Pediatrix Medical has disclosed EBIT across 18 years of filings, most recently posting $41.7 million for Q1 2026.

• In Q1 2026, EBIT rose 29.77% year-over-year to $41.7 million; the TTM figure through Mar 2026 stood at $55.0 million (up 204.77% YoY), while the FY2025 annual figure was $45.5 million, up 166.15% from the prior year.
• EBIT improved to $41.7 million in Q1 2026, from -$114.6 million in the prior quarter.
• Over the last five years, EBIT for MD reached as high as $68.1 million in Q3 2025 and fell as low as -$157.7 million in Q2 2024.
• The 5-year median for EBIT is $39.1 million (2022), against an average of $11.7 million.
• Annual changes were most pronounced in 2024 — EBIT slumped 425.22% — and 2025, when it jumped 137.96%.
• A 5-year view of EBIT shows it stood at $36.0 million in 2022, then tumbled by 409.37% to -$111.5 million in 2023, then jumped by 135.24% to $39.3 million in 2024, then slumped by 391.59% to -$114.6 million in 2025, then surged by 136.36% to $41.7 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $41.7 million, -$114.6 million, and $68.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.